Background Novel direct antiviral agents ( DAA ) targeting hepatitis C virus ( HCV ) have
revolutionized the treatment of chronic hepatitis C infection ( CHC ). Rates of sustained …

Background & Aims We examined the relationship between symptoms of depression and
anxiety and clinical recurrence of inflammatory bowel disease (IBD) in a large patient cohort. …

Background Fatigue is a common symptom of chronic inflammation, including inflammatory
bowel disease (IBD), resulting in significant impairment in quality of life. Aims To identify the …

Infectious complications in patients with cirrhosis frequently initiate episodes of decompensation
and substantially contribute to the high mortality. Mechanisms of the underlying …

Background Inflammatory bowel disease (IBD) can be exacerbated by stress and depression.
Type D personality, characterised by high negative affectivity and social inhibition, …

BACKGROUND The introduction of direct acting antivirals (DAAs) for the therapy of chronic
hepatitis C (CHC) has revolutionised treatment and marks a paradigm shift in the approach …

Background Smoking is a strong environmental factor leading to adverse outcomes in
Crohn's disease, but a more benign course in ulcerative colitis. Several single nucleotide …

Background In 2016, the World Health Organization (WHO) introduced global targets for the
elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide HCV micro-…

Background This study was performed to investigate the efficacy and safety of grazoprevir-elbasvir
guided by baseline resistance-associated substitutions (RASs) in the Swiss HCVree …

Aims and objectives To explore the experiences of being an informal caregiver for a relative
with liver cirrhosis and overt hepatic encephalopathy. Background Overt hepatic …